Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease
- 1 April 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (8), 901-908
- https://doi.org/10.1016/s0002-9149(02)02236-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Novel Inflammatory Markers of Coronary RiskCirculation, 1999
- Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent InstabilityCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy WomenCirculation, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.Heart, 1997
- Production of C-reactive protein and risk of coronary events in stable and unstable anginaThe Lancet, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994